Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
暂无分享,去创建一个
M. Hayden | M. Pouladi | Liang Juin Tan | M. Garcia-Miralles | R. Lin | J. Ooi | L. Tan | C. Bardile | C. Drum | Maya George | Jolene Ooi | Costanza Ferrari Bardile